NewsRoom Articles - Page 446 of 509

TuesdayJun 19, 2018 1:07 pm

Earth Science Tech, Inc. (ETST) Continues Focus on Improved Cannabis-Based Treatments

Updates on CBD patents and medical device progress Working to improve medical treatments on a global scale through its subsidiaries Moving toward uplisting to the OTCQB Venture Market Earth Science Tech, Inc. (OTC: ETST), based in Doral, Florida, is a biotechnology company focused on cannabis, industrial hemp and cannabinoid research and development, including the commercialization of nutraceuticals, pharmaceuticals and medical devices. The company is working to improve medical treatments on a global scale for different diseases through its subsidiaries: Earth Science Pharmaceutical, Cannabis Therapeutics Inc., Kannabidioid Inc. and Canna Inno Laboratories Inc. ETST is in the final phases of preparation…

TuesdayJun 19, 2018 11:48 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Ending the Need to Light-Up

Lexaria is ahead of the game in the expected second flow of investment capital in “plant-to-bloodstream” companies Company’s DehydraTECH™ technology has the potential to revolutionize nicotine use, eliminating the major cause of related deaths by shifting demand away from smoking cigarettes DehydraTECH™ makes it possible to experience most of the positives associated with inhalation while eliminating the negatives, helping to make lighting up a thing of the past Within the cannabis industry, the initial flow of investment capital has been toward ‘seed-to-plant’ companies. As the next stage of investment is expected to be ‘plant-to-bloodstream’, companies such as Lexaria Bioscience Corp.…

MondayJun 18, 2018 2:35 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) in Good Position as Hemp Legalization Efforts Advance

Operations underway on industrial hemp fields in New Brunswick and Oregon United States trending toward national legalization of hemp agriculture Acquisition of 50 percent interest in Cash Crop Today provides successful media and branding resource Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) is pleased to see increasingly favorable prospects for the industrial hemp industry in the United States after the close of “Hemp History Week” (June 4-10) awareness efforts. Although the plant offers no benefit to recreational drug users, it was ensnared in legislative efforts to control its botanical sibling marijuana decades ago. Now, the veil of…

MondayJun 18, 2018 1:12 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) Platform Makes Cannabis Supply Chain Safe and Reliable

Current cannabis testing system lacks integrity BLOCKStrain platform can be trusted for safety and reliability Planned product integration and strategic partnership with bioceutical company The tide of cannabis legalization washing over America is, as might be expected, posing challenges in a number of areas. One is protecting the public, determining how to best ensure that marijuana in the marketplace is safe to consume. The other is producer protection; how can breeders and growers stop their strains from being ‘faked’? The obvious answer is testing, but the testing system that has germinated as cannabis cultivation spreads may not be up to…

FridayJun 15, 2018 12:22 pm

Marijuana Company of America, Inc. (MCOA) Relaunches Improved hempSMART™ Brain Formulation

Significant changes within politics paint a promising picture for the cannabinoid industry MCOA is involved in the cultivation, manufacture and distribution of hemp-derived products MCOA recently announced the launch of its reformulated, patent pending product, hempSMART™ Brain President Trump recently made the statement that he is likely to back the States Act introduced by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA), which removes federal involvement into state-by-state medical and recreational cannabis legislation. This is great news for those in the U.S. cannabinoid market (http://cnw.fm/M4klw). Also, significant changes have taken place in the political acceptance of the cultivation of hemp on…

ThursdayJun 14, 2018 1:35 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appeals to Investors with Slow Burn Rate, Model that Goes Beyond Cannabis Sector

Chris Bunka, CEO of LXRP, in an interview with CFN Media Group, stated that his company’s cash flow is strengthening from licensing and R&D, with technology applicable to other sectors Bunka noted that LXRP’s 71 million share count is kept purposely low relative to others in the category, with its valuation growing by “close to 2,000 percent” over the past several years LXRP’s goal is to slow disease and make cannabis acceptable to the general population Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in…

ThursdayJun 14, 2018 12:32 pm

ChineseInvestors.com, Inc. (CIIX) Expects to Reach Chinese-Speaking Audience of More Than 500,000 with Bitcoin Talk Show

CIIX’s strategy is to blanket Chinese-speaking population in America with daily cryptocurrency broadcast from NYSE, podcast, online site, ATMs, mining operation and educational courses Bitcoin and blockchain show is on Phoenix North America Chinese Channel and will also be broadcast online at NewCoins168.com, CIIX’s website, and its YouTube channel CIIX has established a cryptocurrency mining operation and signed an LOI to acquire the assets of XBTeller.com for some $2.5 million; that company has nine Bitcoin ATMs in Colorado ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a new 22-minute monthly TV program titled ‘Bitcoin Talk Show’, which it expects will reach more…

ThursdayJun 14, 2018 10:53 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is “One to Watch”

Focused on California, the largest legal cannabis market in North America Operates an attractive royalty model that is beneficial for operators and the company Established partnerships with best-in-class operating entities Extensive network provides access to top-tier projects and operators Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages…

WednesdayJun 13, 2018 12:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

WednesdayJun 13, 2018 11:28 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

News and publishing service for cannabis related companies

Contact us: 303.498.7722